Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aarhus University Hospital
Dana-Farber Cancer Institute
Hoffmann-La Roche
Hoffmann-La Roche
Swiss Cancer Institute
ImmunityBio, Inc.
Hoffmann-La Roche
Memorial Sloan Kettering Cancer Center
Exelixis
Memorial Sloan Kettering Cancer Center
Exelixis
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Hoosier Cancer Research Network
Exelixis
Fundacion Oncosur